Tellgen Corporation

Shenzhen Stock Exchange 300642.SZ

Tellgen Corporation Shares (Diluted, Weighted) for the year ending December 31, 2023: 163,145,150

Tellgen Corporation Shares (Diluted, Weighted) is 163,145,150 for the year ending December 31, 2023, a 0.36% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
  • Tellgen Corporation Shares (Diluted, Weighted) for the year ending December 31, 2022 was 162,560,810, a -1.10% change year over year.
  • Tellgen Corporation Shares (Diluted, Weighted) for the year ending December 31, 2021 was 164,370,167, a 0.64% change year over year.
  • Tellgen Corporation Shares (Diluted, Weighted) for the year ending December 31, 2020 was 163,329,207, a 0.54% change year over year.
  • Tellgen Corporation Shares (Diluted, Weighted) for the year ending December 31, 2019 was 162,448,987, a 0.06% change year over year.
Key data
Date Shares (Diluted, Weighted) Revenue Cost of Revenue Gross Profit
Market news
SV Wall Street
Shenzhen Stock Exchange: 300642.SZ

Tellgen Corporation

CEO Mr. Jian Er Yao
IPO Date April 21, 2017
Location China
Headquarters Building 1
Employees 574
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Cosmetics Glass Personal Care Pharmaceuticals Vaccines
Description

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email